Zurex Pharma
Zurex Pharma, Inc. is a privately held specialty pharmaceutical and medical technology company founded in 2008 and headquartered in Middleton, Wisconsin, developing a portfolio of patented antimicrobial formulations intended to prevent healthcare-acquired infections. Its products are physical, regulated goods rather than software: ZuraPrep, a single-use pre-surgical skin antiseptic submitted to the FDA as NDA 210872 in June 2018; ZuraGard for peri-operative and catheter exit-site antisepsis; ZurAsept, a catheter lock solution; and ZuraLac, a teat sanitizer for dairy cattle. Backed by Baird Venture Partners, the State of Wisconsin Investment Board, Peak Ridge Capital and Wisconsin Investment Partners. The company publishes no developer program, no API and no machine-readable API artifacts of any kind, and as of this pass its own domain serves no website.
Zurex Pharma is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Medical Devices, Healthcare, and Antimicrobials.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Clinical Trial Sponsors (drug pipelines) | regulated | 38.8 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.